Applied Cells Receives U.S. Patent Supporting GoFast CAR-T Manufacturing Workflow
We are thrilled to announce that we’ve been awarded U.S. Patent No. 12,595,460 B2, for the Method and Apparatus for Producing CAR-T Cells. The newly
We are thrilled to announce that we’ve been awarded U.S. Patent No. 12,595,460 B2, for the Method and Apparatus for Producing CAR-T Cells. The newly
We are thrilled to share that the MARS® platform was showcased at the ceremonial opening of the new Centre of Excellence CREATIC facilities in Brno
Applied Cells is pleased to announce the expansion of the MARS® Ingenuity™ line with the addition of CD34 Nanobeads, TCR α/β Nanobeads, and CD56 Nanobeads,
Santa Clara, California, and Bengaluru, India, January 13, 2026. Applied Cells Inc. announced today a strategic collaboration framework with Immuneel Therapeutics Private Limited to jointly
We’re excited to announce another significant milestone — Applied Cells has officially submitted a Type II Master File (MAF) for the MARS® Bar system to
We’re excited to share BIG NEWS — Applied Cells is now officially ISO 13485:2016 certified for the design and manufacture of sterile human cell separation
Innate Killer
San Diego, CA | March 3 – 5, 2025
Advanced Therapies
ExCeL, London, UK | March 18 – 19, 2025
Meeting on the Med
Rome, Italy | April 15 – 17, 2025
Cellicon at University of Pennsylvania
Pennsylvania, PA | April 30 – May 2, 2025
ISCT
New Orleans, LA | May 7 – 10, 2025
ASGCT
New Orleans, LA | May 13 – 17, 2025
Allo Summit
Boston, MA | June 10 – 12, 2025
